1. Home
  2. FWDI vs RGNX Comparison

FWDI vs RGNX Comparison

Compare FWDI & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Industries Inc.

FWDI

Forward Industries Inc.

N/A

Current Price

$4.92

Market Cap

560.0M

Sector

Industrials

ML Signal

N/A

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

N/A

Current Price

$7.65

Market Cap

487.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FWDI
RGNX
Founded
1961
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
560.0M
487.2M
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
FWDI
RGNX
Price
$4.92
$7.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
$11.83
★ $21.40
AVG Volume (30 Days)
★ 1.3M
1.2M
Earning Date
12-10-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 18.08
EPS
N/A
★ N/A
Revenue
★ $18,187,525.00
$10,393,000.00
Revenue This Year
$216.73
N/A
Revenue Next Year
N/A
$59.15
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 126.48
52 Week Low
$3.48
$5.46
52 Week High
$9.28
$16.19

Technical Indicators

Market Signals
Indicator
FWDI
RGNX
Relative Strength Index (RSI) 31.78 50.75
Support Level $3.91 $6.79
Resistance Level $5.05 $8.31
Average True Range (ATR) 0.45 0.60
MACD -0.16 0.12
Stochastic Oscillator 5.42 50.65

Price Performance

Historical Comparison
FWDI
RGNX

About FWDI Forward Industries Inc.

Forward Industries Inc is a Solana-focused digital asset treasury company, with the idea to buy, hold, stake, trade, invest in, and grow SOL and SOL-related digital assets, protocols, and businesses. Its mission is to expand and strengthen the Solana ecosystem by acquiring and staking SOL and engaging with, providing tools to, and investing in the Solana network, Solana developers, and Solana-related projects in order to increase shareholder value. In connection with a private placement transaction in September 2025, it launched a digital asset treasury idea supported by investors and operating partners, including Galaxy Digital and Jump Crypto.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: